AmerisourceBergen Corporation has agreed to sell its contract packaging business, AndersonBrecon to an entity formed by affiliates of an investor group led by Frazier Healthcare VI, L.P. for the purpose of acquiring AndersonBrecon. The group is paying $308 million in cash, which is subject to adjustments. AmerisourceBergen is a pharmaceutical services company that serves the United States, Canada and selected global markets.

Click on this morning’s FirstRead to find out more about Frazier Healthcare’s $400m fundraising, Google’s visual dictionary and where to get a top class take-out.

Alcresta, a Newton, Mass.-based company that is developing enzyme-based nutritional products, has raised $10 million in Series A financing led by Bessemer Venture Partners, Frazier Healthcare and Third Rock Ventures. PRESS RELEASE: Alcresta, a company developing innovative enzyme-based nutritional products for infants, adults and patients battling acute or chronic conditions, today announced a $10 million Series [...]

Publicly traded Biogen Idec is buying venture-backed Stromedix Inc. Under the terms of the deal, Biogen Idec will make an upfront cash payment of $75 million and additional payments of up to $487.5 million based on certain milestones. Stromedix’s investors include Atlas Venture, New Leaf Venture Partners, Bessemer Venture Partners, Red Abbey Venture Partners, and [...]

Allena Pharmaceuticals Inc., a company developing oral protein therapeutics, has raised $15 million in a first round of venture funding. Bessemer Venture Partners, Frazier Healthcare and Third Rock Ventures led the Series A round. The funding will help fund development. Allena Pharmaceuticals is based in Newton, Mass.

Frazier Healthcare and New Enterprise Associates have partnered to buy 30 dialysis clinics from DaVita and DSI Renal, the firm announced Monday. The resulting company, DSI, will focus on providing care for patients with chronic kidney failure or end stage renal disease. Healthcare executives Robert Lefton and Craig Goguen will lead the new company, serving as executive chairman and chief executive. The company’s board will include Frazier general partner Nader Naini; NEA partner Mohamad Makhzoumi; NEA general partner Ryan Drant; and Frazier principal Ben Magnano. No terms of the acquisition were released.

Frazier Healthcare has named Tadataka Yamada as a senior executive-in-residence with the firm. Yamada will work with the firm’s growth equity and venture capital teams to pursue investments in healthcare companies in the U.S. and in emerging markets. Yamada was most recently the president of the Global Health Program for the Bill & Melinda Gates Foundation. Frazier Healthcare has $1.8 billion under management.

Frazier Healthcare has completed its acquisition of the Onsite Services instrument management and repair business of publicly traded CareFusion. Financial terms of the deal were not released. OnSite Services delivers education-based medical instrument repair and instrument management programs to hospital systems domestically, the company said in a statement. The deal was first announced in January.

Private equity-backed Informed Medical Communications – a provider of peer-to-peer medical forums, training services and integrated medical communications for the biopharmaceutical industry – has merged with healthcare training company IC Axon. Financial terms of the deal were not released. Edison, New Jersey-based Informed Medical Communications is backed by firm Frazier Healthcare. Montreal-based IC Axon was advised by Fairmount Partners. Excel Partners advised Informed Medical.

Publicly traded Gilead Sciences Inc. will pay $375 million to acquire venture-backed Calistoga Pharmaceuticals, a company developing treatments for cancer and inflammatory diseases. Calistoga could net up an additional $225 million in milestone-based earn-outs. Seattle-based Calistoga has raised more than $90 million from venture investors including Alta Partners, Amgen Ventures, Frazier Healthcare and Three Arch Partners and Latterell Venture Partners.